Source:http://linkedlifedata.com/resource/pubmed/id/19755457
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-9-16
|
pubmed:abstractText |
The athletic performance supplement industry is a multibillion-dollar business and one popular category claims to increase nitric oxide (NO) production. We report three patients presenting to the emergency department with adverse effects. A 33-year-old man presented with palpitations, dizziness, vomiting, and syncope, after the use of NO(2) platinum. His examination and electrocardiogram (ECG) were normal. The dizziness persisted, requiring admission overnight. A 21-year-old man with palpitations and near syncope had used a "nitric oxide" supplement. He was tachycardic to 115 bpm with otherwise normal examination. Laboratory values including methemoglobin, and ECG were unremarkable. He was treated with 1 L of saline with no change in heart rate. He was admitted for observation. A 24-year-old man presented after taking NO-Xplode with palpitations and a headache. His examination, laboratory values, and ECG were normal. He was discharged. The purported active ingredient in these products is arginine alpha-ketoglutarate (AAKG), which is claimed to increase NO production by supplying the precursor L-arginine. The symptoms could be due to vasodilation from increased levels of NO, though other etiologies cannot be excluded. AAKG containing supplements may be associated with adverse effects requiring hospital admission.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/Citrulline,
http://linkedlifedata.com/resource/pubmed/chemical/Ketoglutaric Acids,
http://linkedlifedata.com/resource/pubmed/chemical/L-arginine alpha-ketoglutarate,
http://linkedlifedata.com/resource/pubmed/chemical/Methemoglobin,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1477-0903
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
259-62
|
pubmed:meshHeading |
pubmed-meshheading:19755457-Adult,
pubmed-meshheading:19755457-Arginine,
pubmed-meshheading:19755457-Arrhythmias, Cardiac,
pubmed-meshheading:19755457-Blood Pressure,
pubmed-meshheading:19755457-Citrulline,
pubmed-meshheading:19755457-Dietary Supplements,
pubmed-meshheading:19755457-Dizziness,
pubmed-meshheading:19755457-Electrocardiography,
pubmed-meshheading:19755457-Heart Rate,
pubmed-meshheading:19755457-Humans,
pubmed-meshheading:19755457-Ketoglutaric Acids,
pubmed-meshheading:19755457-Male,
pubmed-meshheading:19755457-Methemoglobin,
pubmed-meshheading:19755457-Nitric Oxide,
pubmed-meshheading:19755457-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Adverse effects associated with arginine alpha-ketoglutarate containing supplements.
|
pubmed:affiliation |
Department of Emergency Medicine and Division of Toxicology, New York City Poison Center, New York University School of Medicine, New York, New York 10016, USA. Jprosser100@gmail.com
|
pubmed:publicationType |
Journal Article,
Case Reports
|